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Adult skeletal muscles adapt their fiber size to work-
load. We show that serum response factor (Srf) is
required for satellite cell-mediated hypertrophic
muscle growth. Deletion of Srf from myofibers and
not satellite cells blunts overload-induced hyper-
trophy, and impairs satellite cell proliferation and
recruitment to pre-existing fibers. We reveal a gene
network in which Srf within myofibers modulates
interleukin-6 and cyclooxygenase-2/interleukin-4 ex-
pressions and therefore exerts a paracrine control of
satellite cell functions. In Srf-deletedmuscles, in vivo
overexpression of interleukin-6 is sufficient to restore
satellite cell proliferation but not satellite cell fusion
and overall growth. In contrast cyclooxygenase-
2/interleukin-4 overexpression rescue satellite cell
recruitment and muscle growth without affecting
satellite cell proliferation, identifying altered fusion
as the limiting cellular event. These findings unravel
a role for Srf in the translation of mechanical cues
applied to myofibers into paracrine signals, which in
turn will modulate satellite cell functions and support
muscle growth.
INTRODUCTION
Adult skeletal muscle is a highly plastic tissue, the mass of which
changes in response to environmental cues and physiological
stimuli. The basic cellular building blocks of adult muscle are
the multinucleated myofibers, which are able to grow during
postnatal growth, during regeneration after injury, and in
response to a functional demand, such as external loads.
Mature myofibers can grow following the addition of new con-
tractile proteins to pre-existing sarcomere units, which involveCthe phosphatidylinositol 3-kinase PI3K/Akt signaling pathway.
Anabolic hormones, such as insulin-like growth factor 1
(IGF1), induce myofiber hypertrophy by activating the Akt1
pathway and the translational machinery through mTOR,
S6K1, and 4E-BP1 (Glass, 2010). Postmitotic myofiber growth
can also result from the accretion of new nuclei provided by
muscle stem cells called satellite cells. Once activated in
response to the adaptive requirements of the muscle, satellite
cells go through an ordered series of events, including prolifer-
ation, migration, and fusion to growing myofibers (Le Grand and
Rudnicki, 2007).
A large set of growth factors and cytokines modulate the pro-
liferation and differentiation of satellite cells (Kuang et al., 2008).
Among these, interleukin 6 (Il6), a myokine detected at high
concentrations in contracting muscle fibers and after increased
load (Carson et al., 2002; Penkowa et al., 2003), enhances satel-
lite cell proliferation and migration during muscle hypertrophy
(Serrano et al., 2008). Muscle-secreted interleukin 4 (Il4)
promotes muscle regeneration and postnatal growth by facili-
tating the migration of myoblasts (Lafreniere et al., 2006) and
the fusion of myoblasts to nascent myotubes (Horsley et al.,
2003). Prostaglandins produced by cyclooxygenase (Cox)
enzymes, which catalyze the rate-limiting step in their synthesis,
are bioactive lipid mediators that can also regulate satellite cell
behavior. In particular, Cox2 isoform activity and Cox2-derived
prostaglandins modulate satellite cell proliferation, migration,
and fusion (Bondesen et al., 2007; Otis et al., 2005; Shen et al.,
2006).
Although significant progress has been made in under-
standing the signaling pathways that control muscle mass, the
molecules that sense muscle overload and translate it into
signals that support hypertrophy are unclear. Furthermore,
very little is known about the transcription factors and target
genes that are involved in promoting adult muscle growth.
Serum response factor (Srf) is a ubiquitously expressed
transcription factor that binds the CArG box sequence. One
major class of Srf targets is expressed specifically in muscles
and comprises several genes encoding sarcomeric proteinsell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc. 25
Figure 1. Srf Loss within Myofiber Impairs Over-
load-Induced Muscle Hypertrophy
Control and Srf-deleted (mutant) plantaris muscles were
obtained from nonoverloaded mice (c) and after 7 and
21 days of compensatory hypertrophy (CH).
(A) Srf protein was analyzed by western blotting. Gapdh
was used as a loading control.
(B) Srf mRNA expression was analyzed by qRT-PCR in
plantarismuscles from control and mutant mice before (c)
and after 7 days of CH. Data (mean ± SEM) were
normalized by 18S rRNA expression. *p < 0.05 versus
controls (c); xp < 0.05 versus controls (7).
(C) Muscle sections immunostained for dystrophin and
nuclear staining with DAPI from control and mutant mice
before (c) and after 21 days of CH.
(D) Ratio of plantaris mass (mg) to body weight (g) before
(c) and after 7 and 21 days of CH in control and mutant
mice. Data are mean ± SEM. *p < 0.01 versus controls (c).
(E) Mean CSA (± SEM) of muscle fibers before (c) and after
7 and 21 days of CH in control and mutant mice. *p < 0.05
versus c.
(F) Mean myofiber number (± SEM) before (c) and after
7 and 21 days of CH in control and mutant mice.
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dynamics has been shown to modulate Srf activity by controlling
the nuclear accumulation of its coactivator, myocardin-related
transcription factor A (Mrtf-A) (Miralles et al., 2003). Data ob-
tained from mouse models with skeletal muscle-specific loss
of Srf orMrtfs functions emphasize their crucial role in postnatal
muscle growth (Charvet et al., 2006; Li et al., 2005). In adults, Srf
activity could also be important for the control of skeletal muscle
growth, as suggested by increased Srf expression during over-
load-induced hypertrophy (Flu¨ck et al., 1999). In cardiac muscle,
Srf and Mrtf-A are necessary for mediating cardiomyocyte
hypertrophy (Kuwahara et al., 2010; Parlakian et al., 2005). Taken
together, these data point toward Srf as a good candidate tran-
scription factor in the control of skeletal muscle mass during
hypertrophy.
To examine the role of Srf during overload-induced muscle
hypertrophy, and the underlying cellular and molecular mecha-
nisms, we used a mouse model of conditional and inducible
deletion of Srf within myofibers but not in satellite cells (Lahoute
et al., 2008). We show here that plantaris myofibers lacking Srf
are no longer able to display a hypertrophic response when
subjected to an experimental overload, thus revealing the
requirement of Srf for muscle growth response to increased26 Cell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc.activity. Using a combination of in vivo and in vi-
tro assays, we demonstrate that this hypertro-
phic growth defect is due to lack of satellite
cell proliferation and fusion to the pre-existing
myofibers, independent of the IGF1/Akt
pathway. We show that impaired production of
secreted factors by myofibers lacking Srf is
responsible for these defects. We also unrav-
eled a gene network associating Srf, Il6, Il4,
and Cox2 genes, which drive overload-induced
muscle growth. By modulating Il6, Cox2/Il4
expression levels in the myofibers, Srf controls
both satellite cell proliferation and fusion. Alto-gether, these data identify Srf as a crucial transcription factor
required for the translation of mechanical cues applied to the
myofibers into paracrine signals that support the proliferation
and fusion of satellite cells, leading to muscle growth.
RESULTS
Srf Is Required for Overload-Induced Hypertrophy
To investigate the role of Srf in skeletal muscle hypertrophy,
compensatory hypertrophy (CH) of the plantaris muscle was
performed in HSA-Cre-ERT2:Srfflox/flox mutant mice previously
tamoxifen-injected to induce myofiber-specific Srf loss. In addi-
tion, control and mutant mice were injected with tamoxifen
during the CH procedure. Efficient Srf loss was achieved at the
protein (Figure 1A) and transcript levels (Figure 1B). As previously
described, no obvious differences in muscle mass, myofiber
cross-sectional area (CSA), and myofiber number were ob-
served between control and mutant plantaris muscles before
overload (Figures 1C–1F, and Lahoute et al., 2008). In this
muscle growth model, we observed a significant increase
in muscle mass (Figure 1D) and the myofibers CSA of control
muscles 21 days after overload (Figure 1E), which was not
accompanied by a modification of fiber number (Figure 1F). In
Figure 2. Srf Is Not Required for IGF1/Akt-Depen-
dent muscle growth
(A) Phosphorylated Akt and total Akt proteins were
analyzed by western blotting from muscle samples ob-
tained from nonoverloaded mice (c) and after 7 and
21 days of compensatory hypertrophy (CH). Gapdh was
used as a loading control.
(B) Myotubes (Srfflox/flox) were transduced with AdGFP or
AdCreGFP (Srf deleted) adenoviruses; 48 hr later they
were treated or not with recombinant 250 ng/ml IGF1
(rIGF1) for an additional 48 hr. Srf protein expression was
analyzed by western blotting. Gapdh was used as
a loading control.
(C) Myotube diameter was measured after AdCreGFP or
AdGFP transduction and after treatment with rIGF1 or not
(). Data aremean ± SEM. *p < 0.05 versus not treated ().
(D) Tibialis muscles were electroporated with control (Ctl)
or Myr-Akt plasmids and isolated 10 days later. Immuno-
staining for P-Akt (green) and nuclear staining with DAPI
illustrated Myr-Akt electroporation. Numbers of DAPI-
stained nuclei within the dystrophin-positive sarcolemma
were counted in nonelectroporated (Nonelec) and Myr-
Akt-electroporated fibers and are expressed per fiber.
Ratio of fiber CSA in electroporated (with Ctl or Myr-Akt
plasmids) or versus nonelectroporated fibers was
measured in control and mutant tibialis muscles. Data are
mean ± SEM. *p < 0.05 versus Ctl plasmid.
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(Figures 1C–1E), showing that Srf is necessary for overload-
induced myofiber hypertrophy.
Srf Is Dispensable for IGF1/Akt-Dependent
Muscle Growth
We investigated the possibility of an alteration in Akt signaling
in mutant muscle. As illustrated in Figure 2A, we observed no
difference in activated Akt levels between control and mutant
muscles at the different times examined after overloading, indi-
cating that Srf deletion in the myofiber does not affect Akt
signaling and that the lack of growth observed in mutant muscle
is not the consequence of altered Akt signaling.
We then determined whether Srf is needed for the recruitment
of new nuclei to the growing myofiber and/or an increase in the
cytoplasmic volume. Having previously shown that myotubes
treated with IGF1 increase in size with no associated increase
of their nuclei number (Ohanna et al., 2005), we assessed
whether myotubes lacking Srf were responsive to IGF1-induced
hypertrophy in culture. The loss of Srf was obtained by trans-
ducing myotubes (Srfflox/flox) with an adenovirus driving Cre
recombinase expression (AdCre) (Figure 2B). IGF1 treatment
led to a similar increase in myotube diameter in both Srf-Cell Metabolism 1expressing and non-Srf-expressing myotubes
(Figure 2C). In addition, in vivo overexpression
of a constitutively active form of Akt1 (Myr-Akt)
can be used to induce muscle hypertrophy
involving myofiber volume increase without
satellite cell fusion (Blaauw et al., 2009). Accord-
ingly, following in vivo gene transfer of aMyr-Akt
vector in control andmutant tibialis muscles, we
observed the same number of myonuclei in bothMyr-Akt-expressing and non-Myr-Akt-expressing myofibers
(Figure 2D, middle). Similar levels of hypertrophy were observed
in control and mutant Myr-Akt electroporated muscles, showing
that Srf is not required for in vivo Myr-Akt-induced hypertrophy
(Figure 2D, right). Taken together, these data demonstrate that
Srf is not required for IGF1/Akt-induced skeletal muscle hyper-
trophy, which depends exclusively on an increase in the cyto-
plasmic volume.
Srf Loss within Myofibers Impairs Satellite
Cell Functions
To analyze the consequences of Srf loss within myofibers on
satellite cell proliferation in vivo during CH, the number of satel-
lite cells expressing both Pax7 (a marker of satellite cells) and
Ki67 (a marker of cycling cells) was quantified. Before CH, the
number of quiescent satellite cells (Pax7+) was similar in control
and mutant plantarismuscles (Figure 3B, left). In contrast, 3 and
7 days after overloading, the number of Pax7+Ki67+ cells was
significantly lower in mutant muscles compared to controls,
showing that in the absence of Srf within myofibers, satellite cells
present a decreased rate of proliferation (Figure 3B, right).
Accordingly, 7 days post-CH, the number of Pax7+ cells was
diminished in mutant muscles (Figures 3A and 3B, left). This5, 25–37, January 4, 2012 ª2012 Elsevier Inc. 27
Figure 3. Srf-Dependent Paracrine Control of Satellite Cell Proliferation and Fusion
(A) Immunostaining for Pax7 (green) and Ki67 (red) to illustrate cycling satellite cells (Pax7+Ki67+, white arrow) after 7 days of CH in control or mutant plantaris
muscles.
(B) Numbers of Pax7+ cells per mm2 and Pax7+Ki67+ cells per mm2 were quantified in control and mutant plantaris muscle sections before (c) and after 3 and
7 days of CH. Data are mean ± SEM. *p < 0.05 versus controls (0); xp < 0.05 versus controls.
(C) Number of DAPI-stained nuclei within the dystrophin-positive sarcolemma was counted before (c) and after 7 and 21 days of CH and are expressed per fiber.
Data are mean ± SEM. *p < 0.05 versus (c); xp < 0.05 versus controls.
(D) Myotubes transducedwith AdGFP (Ctl) or AdCreGFP (Mut) were labeled in green (cell tracker) andmixedwith Ctl myocytes labeled in red (expressing nlslacZ).
After 48 hr of coculture, myotubes were analyzed for dual labeling. Representative picture of the dual labeling: immunostaining for LacZ and GFP/green cell
tracker (yellow arrow). Normalized percentage of fusion events: % of dual labeled myotubes/LacZ cells of myotubes transduced with AdGFP or AdCreGFP
cultured without () or with (+) conditioned medium (CM) from control myotubes. Data are mean ± SEM. *p < 0.05 versus AdeGFP(-CM), xp < 0.05 versus
AdCreGFP(-CM).
(E) Normalized percentage of BrdU+ cells in control myoblasts cultured with or without CM from myotubes transduced with AdGFP or AdCreGFP. Data are
mean ± SEM. *p < 0.05 versus CM from AdGFP.
(F) Immunostaining for Pax7 (green) and Ki67 (red) to illustrate satellite cells (Pax7+) and cycling satellite cells (Pax7+Ki67+) on single fibers. Normalized
percentage of cycling satellite cells (Pax7+Ki67+ over Pax7+ cells) on single fibers isolated from control or mutant EDLmuscles cultured with or without CM from
control myotubes. Data are mean ± SEM. *p < 0.05 versus control, xp < 0.05 versus mutant.
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death as assessed by TUNEL (Figure S1, available online). These
data demonstrate that the presence of Srf within the myofibers is
critical for stimulating efficient satellite cell proliferation in
response to overload.
To investigate whether the lack of Srf in myofibers might also
affect satellite cell fusion to mutant myofibers, myonuclei
numbers were determined in control and mutant plantaris
muscles at various time points post-CH. Although significant
increases in myonuclei numbers were observed in control
muscles at 7 and 21 days post-CH, no such increases were
observed in mutant muscles (Figure 3C). Because decreased
satellite cell proliferation in mutant muscles may impede new
nuclei accretion, we set up an in vitro assay to specifically assess
whether the absence of Srf within myotubes (green) affects
fusion with Srf-expressing mononucleated myocytes (nls-lacZ,
red) (Figure 3D, top). The lack of Srf expression in myotubes
was accompanied by a 50% decrease in fusion events (dual-
labeling, Figure 3D) compared to the control myotubes. These
data show that Srf plays an important role within the myofibers
in controlling satellite cell recruitment.
Altogether, the lack of growth of Srf deficient myofibers in
response to increased load could result from decreased satellite
cell proliferation and decreased ability to fuse to the growing
myofibers.
Srf-Dependent Paracrine Control of Myoblast
Proliferation and Fusion to Myotubes
In this genetic model, Srf deletion occurs in myofibers of mutant
muscles but never in quiescent satellite cells or in satellite cells
engaged in differentiation/fusion (myocytes). Indeed, satellite
cells isolated from mutant single myofibers (from tamoxifen-in-
jected HSA-Cre-ERT2: Srfflox/flox mice) did not display an excision
of floxed Srf allele as opposed to the whole muscle (Figure S2A).
In addition, Srf deletion did not occur in fusing HSA-Cre-ERT2:
Srfflox/flox myocytes (day 1 of differentiation) treated with tamox-
ifen but was observed in terminally differentiated HSA-Cre-ERT2:
Srfflox/flox myotubes (day 5 of differentiation) after tamoxifen
addition (Figure S2B).
We further checked control and mutant muscle-growth
responses in conditions excluding Cre-ERT2 activation in myo-
fibers and in satellite cells during the overloading process.
Because Cre-ERT2 protein is only active in the presence of
tamoxifen, control andmutantmice were injectedwith tamoxifen
only prior to and not during CH. The complete lack of hyper-
trophy observed in mutant muscles as compared to control
muscles 21 days post-CH reinforced our idea that the loss of
Srf onlywithinmyofibers is responsible for the absence of growth
of mutant muscles (Figure S2C).
We therefore hypothesized that during CH myofibers exert
a paracrine control of satellite cell proliferation and fusion via
Srf. The potential involvement of factors secreted from the
myofibers on satellite cell proliferation was first assessed
in vitro by determining the BrdU incorporation rate of control
myoblasts in response to conditioned medium (CM) issued
from both Srf-expressing and non-Srf-expressing myotubes.
CM from myotubes lacking Srf (AdCreGFP-transducted) stimu-
lated myoblast proliferation to a much lesser extent than CM
from control myotubes (AdGFP) (Figure 3E). We further moni-Ctored the percentage of cycling satellite cells (Pax7+Ki67+
over Pax7+) on single-fiber cultures from control and mutant
muscles cultivated in differentiation media (2% HS) or in
presence of CM issued from Srf-expressing myotubes. The
normalized proportion of cycling satellite cells was significantly
decreased in mutant single fibers in comparison with control
single fibers and was restored to control level in presence of
CM (Figure 3F). Thus, the presence of Srf within myofiber/
myotube is necessary for controlling the expression of secreted
factors that promote adequate satellite cell/myoblast prolifera-
tion in vitro.
Whether an alteration of the set of factors secreted by mutant
myofibers could be responsible for inefficient satellite cell fusion
was also investigated in vitro. CM from control myotubes
almost totally rescued the fusion defect of control myocytes to
myotubes lacking Srf (Figure 3D). These data suggested that
CM from control myotubes contained secreted factors that are
no longer produced in Srf-depleted myotubes.
Taken together, these findings highlight a previously undis-
covered contribution of Srf within myofibers in controlling the
expression of secreted factors that are necessary for promoting
the proliferation of muscle satellite cells and their fusion to pre-
existing myofibers during CH.
To identify molecular Srf target genes that control satellite cell
functions, we performed a microarray analysis of gene expres-
sion. Two conditions were used: Srfflox/flox myotubes were trans-
duced with either AdGFP or AdSRFVP16 driving the expression
of a constitutively active Srf derivative. Among the genes whose
expression was induced by SRFVP16, a certain number of
known Srf targets serving as positive controls for the suitability
of the approach were found (Table S1, indicated in italics).
Following qRT-PCR validation, attention was focused on genes
encoding secreted factors that were differentially expressed
between overloaded mutant and control muscles (data not
shown). This was the case for Il6, whose role in Srf-dependent
CH was tested as detailed hereafter.
Il6 Rescues Satellite Cell proliferation
but not Muscle Growth
Il6 has previously been shown to control satellite cell prolifera-
tion in a paracrine manner (Serrano et al., 2008). First, we inves-
tigate a possible Srf-dependent regulation of Il6 expression.
Although a 2.7-fold increase in Il6 expression in gain-of-
function myotubes was observed 2 days post-AdSRFVP16
transduction, Il6 expression decreased by more than half in
the absence of Srf 3 days post-AdCreGFP transduction (Fig-
ure 4A). In vivo, 7 days post-overload, the level of Il6 transcripts
had greatly increased in control plantaris muscles, whereas
only a faint increase was detected in mutant muscles (Fig-
ure 4B). Taken together, these data reveal an impaired Il6
expression in growing muscles lacking Srf, which is intrinsic
to muscle myofibers.
To evaluate the contribution of decreased Il6 expression to the
lack of growth of Srf-deleted myofibers, control and mutant
plantaris muscles were injected with an adeno-associated
virus (AAV) driving Il6 expression (AAV-IL6) 3weeks prior to
CH. Plantaris muscles were isolated 7 and 14 days post-CH
(Figure 4C). A significant increase in Il6 expression was
measured in plantaris muscle injected with AAV-IL6 asell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc. 29
Figure 4. Il6Overexpression Rescues Satellite Cell
Proliferation but Not Overload-Induced Muscle
Growth
(A) Il6 mRNA expression was analyzed by qRT-PCR in
myotubes (SRFflox/flox) transduced with AdGFP or Ad-
CreGFP for 72 hr or with AdSRFVP16 for 48 hr. Data
(mean ± SEM) are normalized by cyclophilin expression
and presented as fold-induction relative to AdGFP.
*p < 0.05 versus AdGFP.
(B) Il6 mRNA expression was analyzed by qRT-PCR in
plantarismuscles from control and mutant mice before (c)
and after 7 days of CH. Data (mean ± SEM) are normalized
by 18S rRNA expression and as fold-induction relative to
controls (c). *p < 0.05 versus controls (c); xp < 0.05 versus
controls (7).
(C) Plantaris muscles from one leg of control and mutant
mice were injected with AAV-IL6 21 days prior to muscle
overloading procedure of both legs. Muscles were iso-
lated after 7 days of CH for satellite cell proliferation and
fusion analyses, and after 14 days of CH for satellite cell
fusion and overall growth analyses.
(D–F) Numbers of Pax7+ cells per mm2 (D), Pax7+Ki67+
cells per mm2 (E), and myonuclei per fiber (F) were quan-
tified in control and mutant plantaris muscle sections in-
jected (+) or not () with AAV-IL6 after 7 days of CH. Data
are mean ± SEM. *p < 0.05 versus controls (-); xp < 0.05
versus mutants ().
(G) Muscle sections immunostained for dystrophin and
mean CSA (± SEM) from control and mutant muscles
injected (+) or not () with AAV-IL6 after 14 days of CH.
*p < 0.05 versus controls ().
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Il6 overexpression did not affect the numbers of Pax7+ and
Pax7+Ki67+- proliferating satellite cells in control muscles
7 days post-CH, suggesting that the level of Il6 in control
muscles does not limit growth. Significantly, the numbers of
satellite cells (Pax7+, Figure 4D) and proliferating satellite cells
(Pax7+Ki67+, Figure 4E) increased to control levels in overloaded
mutant muscles overexpressing Il6, indicating a functional role
for decreased Il6 expression in the altered satellite cell prolifera-
tion of mutant CH muscles. In contrast, Il6 overexpression was30 Cell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc.not able to rescue the altered fusion of satellite
cells to the growing Srf-deleted myofibers: at 7
and 14 days post-CH, the mean myonuclei
number was unchanged in mutant myofibers
and was still inferior to that of control myofibers
(Figure 4F and S3B). Finally, overall growth was
assessed by measuring the mean CSA of
myofibers in AAV-IL6-injected and non-AAV-
IL6-injected muscles 14 days post-CH. Il6
overexpression had no effect on the growth
of control and mutant myofibers, and the
mean CSA of myofibers lacking Srf remained
lower than that of controls (Figure 4G). Taken
together, these data demonstrate that Il6 over-
expression was able to rescue in vivo satellite
cell proliferation in mutant muscles but not
satellite cell fusion and myofiber growth. There-
fore, decreased satellite cell proliferation is notthe major limiting step for hypertrophy in response to overload
in Srf-deleted muscles.
Il4 Restores Satellite Cell Fusion and In Vivo
Muscle Growth
To discern whether altered satellite cell recruitment could deter-
mine the lack of hypertrophy of Srf-deleted myofibers, the genes
involved must be identified. Il4 is a good candidate because 1) it
has previously been shown to control fusion of myoblasts to
nascent myotubes during postnatal growth (Horsley et al.,
Figure 5. Il4 Overexpression Restores Satellite Cell Fusion and Muscle Growth
(A) Il4 mRNA expression was analyzed by qRT-PCR in myotubes (SRFflox/flox) transduced with AdGFP or AdCreGFP for 72 hr or with AdSRFVP16 for 48 hr.
Data (mean ± SEM) are normalized by cyclophilin expression and presented as fold-induction relative to AdGFP. *p < 0.05 versus AdGFP.
(B–D) Numbers of Pax7+ cells per mm2 (B), Pax7+Ki67+ cells per mm2 (C), and myonuclei per fiber (D) were quantified in control and mutant plantaris muscle
sections injected (+) or not () with AAV-IL4 after 7 days of CH. Data are mean ± SEM. *p < 0.05 versus controls (); xp < 0.05 versus mutants ().
(E) Muscle sections immunostained for dystrophin and mean CSA (± SEM) from control and mutant muscles injected (+) or not () with AAV-IL4 after 14 days
of CH. *p < 0.05 versus controls (); xp < 0.05 versus mutants ().
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etal muscle-specific loss ofSrf has been correlated to decreased
Il4 expression (Charvet et al., 2006). In primary myotubes lacking
Srf (AdCreGFP-transduced for 3 days), Il4 expression is reduced
by 40% when compared to control myotubes (AdGFP) (Fig-
ure 5A). To determine whether decreased Il4 expression could
account for defective fusion of control myocytes to Srf-deleted
myotubes, in vitro fusion experiments were conducted using
CM issued from Il4/myotubes and exogenous Il4. Importantly,
Il4 addition rescued fusion, whereas CM from Il4/ myotubes
did not ameliorate fusion (Figure S4). The implication of
decreased Il4 expression in the lack of growth in Srf-deleted
muscles was then addressed in vivo by injecting control and
mutant plantaris muscles with an AAV driving Il4 expression
(AAV-IL4) prior to CH. A robust Il4 overexpression wasmeasured
in plantaris muscle injected with AAV-IL4 (Figure S5A). When Il4
was overexpressed in control muscles on day 7 post-CH, the
number of Pax7+ cells was unchanged and the number of
proliferating Pax7+Ki67+ satellite cells was lower, suggesting
that Il4 might drive satellite cells toward fusion and accelerate
the growth process. In mutant muscles, we observed that Il4
overexpression had no effect on the total number of Pax7+ or
Pax7+Ki67+ satellite cells (Figures 5B and 5C). Most interest-
ingly, the impaired fusion of satellite cells to mutant myofibers
was fully rescued by Il4 overexpression, as assessed by count-Cing myonuclei numbers 7 and 14 days post-CH (Figures 5D
and S5B). Moreover, Il4 overexpression was able to rescue the
lack of response to overload in mutant muscle because mutant
plantaris muscle was now able to grow following an overload-
induced hypertrophy (Figure 5E). The 30% increase in size of
mutant myofibers expressing Il4 allowed mutant muscles to
reach the size of hypertrophied control muscles.
Taken together, these data show that Il4 is necessary for Srf-
controlled fusion in vitro and is sufficient to rescue both the
impaired satellite cell fusion of Srf mutant muscles and their
lack of hypertrophic growth in vivo without improving the
decreased proliferation of satellite cells. These results suggest
that satellite cell fusion to myofibers is the main limiting step
for growth occurring in myofibers lacking Srf. In addition, we
identify Il4 in vivo as a crucial secreted factor involved in the
paracrine control of satellite cell fusion during CH.
Cox2 Is a Direct Srf Target Gene and Controls
Il4 Expression
Whether Il4 could be a direct target gene of Srf, as found in the
muscle cell line C2C12 (Charvet et al., 2006), was further inves-
tigated through ChIP experiments. In contrast to the results in
C2C12 cells, none of the putative CArG boxes of Il4 promoter
bound Srf protein in cultured primary myotubes (Figure S6A).
However, Srf was bound to a-skeletal actin andmyl9 promoters,ell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc. 31
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attributed to the different cellular systems used in this study.
To further examine the potential control of Il4 transcription by
Srf, various Il4 promoter-reporter constructs were created and
the luciferase activity in the presence or absence of activated
Srf (SRFVP16) was analyzed. SRFVP16 onlymarginally activated
pIL4(1670) reporter construct, which contains two of the
putative Srf binding sites, and pIL4(838) reporter, which lacks
putative CArG boxes (Figure S6B). In line with these results,
endogenous Il4 expression was not modulated in gain-of-func-
tion myotube samples in a short time point post-AdSRFVP16
transduction (2 days) which favors the regulation of direct Srf
target genes rather than secondary targets (Figure 5A). Taken
together, these data argue against a direct regulation of Il4 by
Srf in primary myotubes.
We looked for potential candidate genes whose expression
could be directly regulated by Srf and potentially linked to Il4
expression in the list of genes upregulated upon Srf activation
(Table S1). Attention was focused on the Cox2 gene, whose
activity has been reported to be required for skeletal muscle
hypertrophy (Novak et al., 2009). A common signaling pathway,
the calcineurin/NFAT pathway, has previously been implicated in
the control of fusion by Cox-derived prostaglandins and in the
regulation of Il4 expression in muscle cells (Horsley et al.,
2003; Horsley and Pavlath, 2003). We first confirmed by qRT-
PCR that Cox2 expression is greatly increased in myotubes
transduced with AdSRFVP16, whereas a significant decrease
of Cox2 expression in myotubes lacking Srf was observed (Fig-
ure 6A). Interestingly, an increase of Cox2 expression in control
muscles, which was significantly blunted in Srf-deleted muscles,
was observed 7 days post-CH (Figure 6B), thus reinforcing the
potential role of Cox2 in Srf-dependent growth. To decipher
whether Cox2 could be a direct target of Srf, Cox2 reporter
plasmids were constructed and we showed that SRFVP16
increased the activation of pCox2(2570) reporter by 3.5-fold.
In contrast, the pCox2(2250) reporter was activated signifi-
cantly less, suggesting the presence of a Srf-responding region
in the portion2570 to2250 of the Cox2 promoter (Figure 6C),
which contains a putative CArG motif at position 2320. In ChIP
experiments performed in primarymyotubes, theCox2 promoter
covering position 2320 was robustly amplified from Srf immu-
noprecipitates compared to IgG controls, demonstrating Srf
binding (Figure 6D). Together, these results suggest that Cox2
expression is directly regulated by Srf through binding to
a CArG motif at position 2320 of the Cox2 promoter.
To gain insight into the possible regulation of Il4 expression
by Cox2, primary myotubes were treated with a specific Cox2-
inhibitor (SC-791) and Il4 transcripts were quantified. Cox2
inhibition led to a 40% decrease of Il4 expression in a dose-
response manner (Figure 6E). This effect seemed to be specific
to Il4 because Il6 and Srf expression levels were unaffected
under the same conditions (data not shown). More importantly,
in transfection experiments, Cox2 overexpression was able
to increase the activation of the pIL4(1730) reporter more
than 5-fold (Figure 6F). In addition, both treatments with cyclo-
sporin (CsA), a potent inhibitor of calcineurin, and coexpression
of VIVIT, a NFAT inhibitory peptide, significantly decreased
Cox2-induced activation of the pIL4(1730) reporter, showing
that at least part of this activation is dependent upon the32 Cell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc.calcineurin/NFAT pathway (Figure 6F). To investigate whether
Cox2 could regulate Il4 expression in vivo, AAV driving Cox2
expression (AAV-Cox2) was injected in plantaris muscle. AAV-
Cox2 injection strongly increased Cox2 expression (Figure S7A).
Post-CH, the overexpression of Cox2 increased by 4.5-fold the
amount of endogenous Il4 transcripts, whereas Il6 transcript
levels were unaffected (Figure 6G). Overall, these data suggest
that Cox2 positively regulates Il4 gene transcription in skeletal
muscle.
Cox2 Rescues Satellite Cell Fusion and Overall
Muscle Growth
If direct control of Cox2 expression by Srf mediates muscle
growth through Il4, it is expected that Cox2 overexpression
in vivo will rescue Srf-deleted myofiber growth in a similar
manner to Il4. Therefore, control and mutant plantaris muscles
were injected with AAV-Cox2 prior to CH. Cox2 overexpression
had no effect on satellite cell proliferation and fusion in control
muscles. Significantly, after overload-induced hypertrophy of
mutant muscles, Cox2 overexpression did not influence the
number of proliferating satellite cells (Figures 7A and 7B) but still
effectively rescued to control levels in both satellite cell fusion
(Figure 7C and S7B) and overall growth of Srf-deletedmyofibers.
Indeed, mean CSA of mutant plantaris muscles injected with
AAV-Cox2 was comparable to control muscles (Figure 7D)
and, thus, display a rescue of growth similar to that obtained
by Il4 overexpression (Figure 5E).
These data show a previously unknown Srf-dependent para-
crine control of muscle growth by Cox2/Il4 within myofibers.
DISCUSSION
Taking advantage of a genetic model that allows the invalidation
of Srf in myofibers and not in satellite cells, we demonstrate
that the recruitment of satellite cells to the myofibers is a limiting
step for physiological hypertrophy in adult Srf-deleted muscles.
We provide evidence for a gene network operating in myofibers
during overload-induced muscle growth in which Srf modulates
Il6 and Cox2/Il4 expression levels, which control satellite cell
proliferation and fusion, respectively. We propose that, within
overloaded myofibers, Srf acts as a sensor for mechanical
cues that translates them into paracrine signals, which in turn
regulate satellite cell functions and support muscle growth
(Figure 7E).
Two nonexclusive mechanisms are involved in muscle growth:
1) the increase of net protein content through the activation of
Akt/TOR pathway and 2) the addition of satellite cell-derived
myonuclei to the adult myofiber. Our data show that the lack of
recruitment of satellite cells is responsible for the absence of
compensatory hypertrophy in Srf-deleted muscles. Indeed, an
absence of Srf does not compromise Akt signaling and Srf is
dispensable for Akt-driven muscle growth that does not involve
satellite cells. Using in vivo and in vitro experiments, we further
deciphered the Srf-dependent molecular and cellular events
that could be implicated in overload-induced hypertrophy. Our
data show that, in response to overload, Srf within myofibers
controls both satellite cell proliferation and fusion in a paracrine
manner. Srf promotes the production of extracellular factors (Il6
and Il4) by the myofiber and, thus, controls the satellite cell local
Figure 6. Cox2 Is a Direct Target of Srf and Vontrols Il4 Expression
(A)Cox2mRNA expression was analyzed by qRT-PCR inmyotubes (SRFflox/flox) transducedwith AdGFP or AdCreGFP for 72 hr or with AdSRFVP16 for 48 hr. Data
(mean ± SEM) are normalized by cyclophilin expression and presented as fold-induction relative to AdGFP. *p < 0.05 versus AdGFP.
(B)Cox2mRNA expressionwas analyzed by qRT-PCR in plantarismuscles from control andmutantmice before (c) and after 7 days of CH. Data (mean ± SEM) are
normalized by 18S rRNA expression and as fold-induction relative to controls (c). *p < 0.05 versus controls (c); xp < 0.05 versus controls (7).
(C) Deletion analysis of Cox2 promoter fragments ranging from 2570 to +1, cloned in front of a luciferase reporter and cotransfected with SRFVP16.
Putative CArG box is indicated. Shown is the mean of relative luciferase activity (± SEM) normalized to Renilla luciferase. *p < 0.05 versus pCox2(2570)
SRFVP16.
(D) ChIP performed using myotubes and antibodies specific to Srf or IgG. Bound Cox2 promoter was amplified by qRT-PCR and normalized to input and to an
additional negative control (primers spanning the first intron of Il4). Data are mean ± SEM. *p < 0.05 versus IgG.
(E)Cox2mRNA expression was analyzed by qRT-PCR in myotubes (SRFflox/flox) treated with Cox2 inhibitor (SC-791) for 48 hr. Data (mean ± SEM) are normalized
by cyclophilin expression and as fold-induction relative to untreated. *p < 0.05 versus (0).
(F) Responsiveness of pIL4(1670) luciferase reporter construct to Cox2 treated with calcineurin inhibitor (CsA) or cotransfected with a NFAT inhibitor (VIVIT).
Data are mean ± SEM. *p < 0.05 versus pIL4(1670) alone, xp < 0.05 versus pIL4(1670) plus Cox2.
(G) Il4 and Il6 mRNA expressions were analyzed by qRT-PCR in control plantaris muscles injected (+) or not () with AAV-Cox2 after 7 days of CH. Data
(mean ± SEM) are normalized by cyclophilin expression and as fold-induction relative to ().*p < 0.05 versus ().
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Figure 7. Cox2 Recues Satellite Cell Fusion and Muscle Growth
(A–C) Numbers of Pax7+ cells per mm2 (A), Pax7+Ki67+ cells per mm2 (B) and myonuclei per fiber (C) were quantified in control and mutant plantaris muscle
sections injected (+) or not () with AAV-Cox2 after 7 days of CH. Data are mean ± SEM. *p < 0.05 versus controls (); xp < 0.05 versus mutants ().
(D) Muscle sections immunostained for dystrophin andmean CSA (± SEM) from control andmutant muscles injected (+) or not () with AAV-Cox2 after 14 days of
CH. *p < 0.05 versus controls (); xp < 0.05 versus mutants ().
(E) Schematic model: in response to increased workload, Srf withinmyofibersmodulates Il6 andCox2/Il4 expressions and, therefore, exerts a paracrine control of
satellite cell proliferation and fusion, respectively, which in turn support skeletal muscle hypertrophy.
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coordinated regulation by Srf of both satellite cell proliferation
and fusion ensures proper muscle growth in response to
increased load. We verified that Il6 and Il4 do not stimulate the
hypertrophy of fully differentiated myotubes in an autocrine
manner because myotubes treated with Il6 or Il4 did not display
an increase in size (data not shown).
It is notable that reduced proliferation of satellite cells is not the
limiting step responsible for the lack of hypertrophy of muscles
deleted for Srf because the normalization of satellite cell prolifer-34 Cell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc.ation by Il6 overexpression did not improve satellite cell fusion
and was unable to drive muscle hypertrophy. In contrast, the
restoration of satellite cell fusion by either Il4 or Cox2 overex-
pression was sufficient to rescue overload-induced growth of
muscles lacking Srf. Interestingly, this rescue was obtained
without any increase in satellite cell proliferation, showing that
satellite cell fusion was the major limiting cellular event. The
number of cycling satellite cells remaining inSrf-deletedmuscles
(50%) was probably sufficient to support growth when fusion is
restored. This situation differs from that reported for Il6/
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attributed mainly to a defect in satellite cell proliferation (Serrano
et al., 2008). In that case, satellite cell proliferation was more
profoundly affected (with only 30% of cycling satellite cells left)
than muscles lacking Srf. Our data support an important role
for satellite cell recruitment in activity-induced hypertrophy of
Srf-deleted muscles and are in line with a recent study showing
that increased fiber size during compensatory hypertrophy is
preceded by the addition of nuclei and that this constitutes the
major cause of hypertrophy (Bruusgaard et al., 2010). Interest-
ingly, overload-induced muscle hypertrophy can still take place
in the absence of satellite cells (McCarthy et al., 2011). The
compensatory mechanism allowing growth in satellite cell-
depleted skeletal muscle may be impaired in our model due to
the lack of Srf expression in myofibers.
While searching for mechanisms underlying such defects in
satellite cell recruitment, the Srf gain of function transcriptome
study led us to focus our interest on the Cox2 gene. Here, we
show that Cox2 expression increases strongly in response to
muscle overload in a Srf-dependent manner, and also show
that Cox2 is a direct target gene of Srf in differentiated muscle
cells. Significantly, the sole restoration ofCox2 expression inmy-
ofibers lacking Srfwas able to rescue satellite cell recruitment to
the growing fiber and to subsequent muscle growth. This study
constitutes the first in vivo demonstration of the specific implica-
tion of Cox2 activity within the myofiber for the control of satellite
cell fusion during overload-induced hypertrophy. Interestingly,
Cox2 activity has been shown to be required for efficient muscle
regeneration (Bondesen et al., 2004; Shen et al., 2006), recovery
from atrophy (Bondesen et al., 2006), and overload-induced
hypertrophy (Novak et al., 2009). However, in this last case, the
blunting of muscle growth by a specific Cox2 inhibitor was attrib-
uted to reduction of macrophage accumulation, extracellular
protease activity, and overall cell proliferation. The effect on
proliferation was relatively modest and did not discriminate
satellite cells from other cell types. In our experimental pro-
cedure of hypertrophy, inflammation did not appear to be
differentially modulated between mutant and control muscles
as assessed by quantifying macrophage-specific genes ex-
pression levels and F4/80 positive cells on muscle sections
(data not shown). Moreover, our present data argue against
paracrine control of satellite cell proliferation by Cox2 during
hypertrophy because Cox2 overexpression in Srf-deleted myo-
fibers failed to rescue satellite cell proliferation.
How could a Srf-dependent increase of Cox2 expression in
myofibers control satellite cell fusion during overload? We
propose that Cox2 and Il4 genes are linked. Here, we show for
the first time the implication of Il4 during overload-induced
muscle hypertrophy. As for Cox2, in vivo overexpression of Il4
in Srf-deleted myofibers was sufficient to restore satellite cell
fusion and muscle growth. However, in contrast to Cox2, Il4
does not appear to be a direct target gene of Srf in myotubes
derived from primary cultures. Significantly, our data clearly
demonstrate that Cox2 controls Il4 expression. Indeed, inhibition
of Cox2 activity downregulates endogenous Il4 expression in
cultured myotubes, whereas Cox2 overexpression activates
the Il4 promoter. Moreover, AAV-driven Cox2 overexpression
was sufficient to increase the amount of endogenous Il4 tran-
scripts in vivo. These data constitute the first report showingCthe upregulation of Il4 expression by Cox2 in muscle cells.
Thus, Il4 could mediate at least some of the action of Cox2 on
satellite cell recruitment during muscle overload. Furthermore,
we show that the calcineurin/NFAT pathway relays in part the
increase of Il4 expression by Cox2 activity. Because Cox2-
derived prostaglandin PGF2a has been shown to control myo-
blast fusion with nascent myotubes in a NFATc2-dependent
manner (Horsley and Pavlath, 2003) and Il4 expression has
been shown to be controlled by NFATc2 (Horsley et al., 2003),
NFATc2 could be the transcription factor that links Cox2 to Il4
activation.
The adaptation of skeletal muscle to external mechanical
stress, such as increased loading, requires initial sensing of the
stress by myofibers, followed by its transduction into signals
that will generate the appropriate physiological response. We
show that, within myofibers, Srf is required for muscle growth
in response to increased loading but is dispensable for Myr-
Akt-induced muscle hypertrophy, which occurs in the absence
of increased mechanical signals. Another difference between
these two growth models is that only overload-induced hyper-
trophy relies on the recruitment of satellite cells. Therefore, it
appears that Srf may be a central transcription factor required
for the translation of mechanical signals into a myofiber tran-
scriptional program leading to local milieu modifications that
are interpreted by satellite cells and support muscle growth.
Several observations support the role of Srf as a sensor of
mechanical cues. In cardiac muscle cells, the nuclear localiza-
tion of the Srf cofactor Mrtf-A is induced by mechanical stretch
and Mrtf-A/ mice show significantly attenuated mechanical
stress-induced cardiac hypertrophy (Kuwahara et al., 2010). In
human skeletal muscle, STARS (an activator of Srf by increasing
actin polymerization),MRTFs, and SRF expressions are upregu-
lated following resistance training-induced hypertrophy (Lamon
et al., 2009), and Stars expression level is increased during
overload-induced muscle hypertrophy in mice (data not shown).
Collectively, these observations point to the Rho-actin-Mrtf-Srf
pathway as a signaling mechanism mediating mechanical
stress-induced gene expression and hypertrophic responses.
In this study, we show that, within myofibers, Srf is a key regu-
lator of skeletal muscle hypertrophy in response to workload by
enhancing satellite cell proliferation and their subsequent fusion
to the growing fibers in a paracrine fashion through Il6 and
Cox2/Il4, respectively. Interestingly, hypertrophy induced by
overload is greatly attenuated in older animals (Alway et al.,
2002; Carson et al., 1995). We previously reported a decreased
expression of Srf in aged human and mouse muscles. Accord-
ingly, loss of Srf within myofibers of young adult mice induced
premature aging in skeletal muscle (Lahoute et al., 2008). There-
fore, during aging, there is a further link between Srf activity
and muscle hypertrophic capacities. Thus, the identification of
Srf as a master controller of physiological hypertrophy carries
potential significance in the search for muscle atrophy therapies
and treatments alleviating muscle aging.EXPERIMENTAL PROCEDURES
Mouse Protocols
Mice homozygous for Srf floxed alleles (Srfflox/flox) and HSA-Cre-ERT2:
Srfflox/flox tamoxifen-dependent Cre recombinase premutant mice have beenell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc. 35
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pre-mutant and Srfflox/flox female mice were given intraperitoneal tamoxifen
(1 mg per day; Sigma) injections for 5 consecutive days and are referred as
mutants and controls, respectively.
Compensatory hypertrophy (CH) of plantaris muscles was induced as
described (Serrano et al., 2008). During the process of CH, control and mutant
mice were injected with tamoxifen every 3 days. A minimum of four animals of
each genotype were analyzed for every experiments. Control and mutant
plantaris muscles were injected with 7 3 1010 viral AAV genomes. Mice were
given a 3-week recovery period, allowing the expression of the transgene
before performing CH.
For electrogene transfer, tibialismuscles were injected with 8 U of hyaluron-
idase 1 hr prior injection of 15 mg pMyr-Akt or 5 mg pH2B-CFP+10 mg pCDNA3
plasmids. Six 65 V/cm pulses of 60 ms, with a 100-ms interval, were applied.
Muscles were collected 10 days after gene delivery.
All experiments were conducted in accordance with European guidelines
for the care and use of laboratory animals and were approved by the institu-
tional animal care and use committee.
Plasmids and Viral Productions
For detailed plasmid and viral productions descriptions, see Supplemental
Information.
Primary Muscle Cell Culture and Infections
Primary cultures were derived from hindlimb muscles of Srfflox/flox mice and
cultured as described (Ohanna et al., 2005). Myoblasts were grown in growth
medium (DMEM/F12, 2% Ultroser G, 20% Fetal Calf Serum). For differentia-
tion, myoblasts were seeded in Matrigel-coated dishes and cultured in differ-
entiation medium (DM; DMEM/F-12, 2% horse serum).
Myotubes at day 2 of differentiation were transduced with 2 i.p./cell of
adenoviruses AdGFP, AdCreGFP, or AdSRFVP16.
Myotubes were treated with Cox2-inhibitor II (SC-791, Calbiochem; 5 and
15 mM) or cyclosporine (Csa, Sigma, 5 mM), added daily to DM.
To generate a stable cell line expressing nls-LacZ, myoblasts were infected
twice with the supernatant of a stable 293 Phoenix cell line producing nls-LacZ
retrovirus and 8 mg /ml of polybrene.
Single-Fiber Culture
Individual fibers were isolated from EDL muscles as described (Rosenblatt
et al., 1995). Myofibers were grown as nonadherent cultures for 48 hr in
DMEM medium supplemented with 2% horse serum or in conditioned media
from control myotubes.
To detect cycling satellite cells, single myofibers were immunostained using
anti-Pax7 (Santa Cruz) and anti-Ki67 (Abcam) and counterstained with DAPI.
The % of Pax7+Ki67+ cells is represented as relative to the total number of
Pax7+ cells. At least 60 cells were counted for each assay.
Fusion and Proliferation Assays
To analyze fusion, myotubes at day 2 of differentiation transduced with Ad-
CreGFP or AdGFP were loaded with 6 mM of Green Cell Tracker (Molecular
Probes) for 15 min and then were cocultured with nls-LacZ myocytes
(myoblasts incubated overnight in DM). When indicated, conditioned media
(CM) from control myotubes was added. Two days later, fusion events were
scored after immunostaining with anti-LacZ antibody (Invitrogen) by counting
the dual-labeled cells (green cells GFP+/ nls-lacZ+). The number of fusion
events was normalized by the number of stained nls-LacZ nuclei. The pres-
ence of dual labels was analyzed in 70–150 myotubes in each experiment.
To detect S phase entry, Srfflox/flox myoblasts were cultured for 12 hr in
CM from SRFflox/flox myotubes transduced with AdCreGFP or AdGFP
supplemented with 10% FCS, 0.1% Ultroser and pulsed with BrdU (Sigma;
5 mg/ml) for 2 hr prior to fixation and subsequent immunostaining using
anti-BrdU antibody (Dako). The percentage of BrdU+ cells is represented as
relative to total number of cells counted. At least 1,000 cells were counted
for each assay.
Isolation of mRNA, RT-PCR, and qRT-PCR
Total RNA was extracted using TRIzol reagent and reverse-transcribed with
VILO reverse transcriptase (Invitrogen). Quantitative PCR analysis was per-36 Cell Metabolism 15, 25–37, January 4, 2012 ª2012 Elsevier Inc.formed using a Light Cycler instrument with SYBR Green I kit (Roche). Primer
sequences are listed in Supplemental Information. The values were normalized
to housekeeping genes 18S rRNA or Cyclophilin.
ChIPs
Myotubes (5.106 cells) were fixed with 1% paraformaldehyde for 11 min. For
each immunoprecipitation, sonicated chromatin was incubated with 3 mg
anti-Srf (G20, Santa Cruz) or IgG and immunocomplexes were recovered
using a Magna ChIP G Kit (Millipore). Quantification of immunoprecipitated
DNA was done by real-time PCR using the appropriated primers (see Supple-
mental Information) and reported to input chromatin. Results shown are
normalized to the recovery of a non-Srf-regulated gene region (in the intronic
part of Il4).
Reporter Assays
Fifty thousand myoblasts were transfected using Lipofectamine 2000 reagent
(Invitrogen) with 80 ng luciferase plasmid reporter, 100 ng pRL-TK and 200–
400 ng of indicated plasmid in a total of 800 ng DNA. Twenty-four hours
post-transfection, cells were cultured in DM and harvested 24 hr later. Firefly
and Renilla luciferase activities were determined using the Dual-Luciferase
Reporter Assay System (Promega). Each experiment was performed in tripli-
cate and repeated three times.
Immunostaining
Plantaris muscles were frozen in cooled isopentane and cut in 7 mm-thick
sections. Fiber size, myonuclei number, and satellite cells were analyzed
by immunostaining using anti-dystrophin (Novocastra), anti-P-Akt (Cell
Signaling), anti-Pax7 (Santa Cruz), and/or anti-Ki67 (Abcam) and DAPI stain-
ing. Between 300 and 600 myofibers were analyzed per muscle. The distribu-
tion of fiber cross-sectional area was determined using Metamorph.
Western Blot Analysis
Western blotting was performed as described (Lahoute et al., 2008). Immuno-
blots were done using anti-phospho-Akt Ser473 and anti-Akt (Cell Signaling),
anti-Srf, and anti-Gapdh (Santa Cruz) antibodies.
Statistical Analysis
The significance of differences betweenmeans was assessedwith a Student’s
t-test. P values of < 0.05 were considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Proce-
dures, seven figures, and one table and appears with this article online at
doi:10.1016/j.cmet.2011.12.001.
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